YMR315W-A Antibody

Shipped with Ice Packs
In Stock

Description

Contextualizing YMR315W-A in Yeast Genomics

Yeast GeneChromosomal LocationORF TypeFunctional Category
YMR315W-AChromosome XIII (Right Arm)Dubious ORFUncharacterized

This ORF lacks experimental validation for protein expression, and its biological role remains undefined. Antibodies targeting such genes are typically polyclonal or monoclonal tools for exploratory research.

Antibody Development for Uncharacterized Targets

For hypothetical YMR315W-A antibody production, standard workflows would apply:

Table 1: Antibody Production Steps (Adapted from34)

StepMethodologyPurpose
Antigen DesignSynthetic peptide from predicted YMR315W-A sequenceImmunogen synthesis
ImmunizationRabbit/mouse hosts with KLH-conjugated peptideElicit immune response
Hybridoma GenerationFusion of splenocytes with myeloma cells (for mAbs)Clone antibody-secreting cells
ValidationWestern blot, immunofluorescence (yeast lysates)Confirm specificity

Challenges in Targeting Dubious ORFs

  • Low Antigenicity: Short/poorly conserved peptide sequences reduce immunogenicity.

  • Cross-Reactivity Risk: Homology with functional yeast proteins necessitates stringent validation .

  • Functional Ambiguity: Without confirmed protein expression, antibody utility is limited to exploratory assays.

Table 2: Antibody Classes and Applications (Data from1210)

ClassMolecular Weight (kDa)Serum AbundanceTypical Use
IgG15080%Therapeutic, diagnostic
IgM9006%Early immune response
IgA38513%Mucosal immunity
IgE2000.002%Allergic reactions

For uncharacterized targets like YMR315W-A, IgG antibodies are preferred due to their stability and ease of purification .

Research Implications

While no direct data exists for YMR315W-A, analogous studies on dubious ORFs (e.g., S. cerevisiae YDR034W-B ) show:

  • Epitope Mapping: Requires >12-mer peptides with 60% sequence accessibility .

  • Validation Metrics: ≥3 independent assays (e.g., ELISA, knockdown lysates) to exclude off-target binding .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YMR315W-A antibody; Uncharacterized protein YMR315W-A antibody
Target Names
YMR315W-A
Uniprot No.

Q&A

What is YMR315W-A and what cellular functions is it involved in?

YMR315W-A is a yeast gene that encodes a protein involved in cellular degradation pathways. Current research indicates it functions as a negative regulator of autophagy and is a transcriptional target of the yeast transcription factor Stb5 . Studies have shown that chromosomal deletion of YMR315W enhances starvation-induced autophagy, suggesting its role in modulating this critical cellular process . The protein appears to be part of a larger cellular network involving metabolism and protein degradation pathways, particularly in the context of the ubiquitin-proteasome system and endoplasmic reticulum associated degradation (ERAD) .

YMR315W-A exists within a broader context of cellular degradation mechanisms as shown in the table below:

Cellular SystemYMR315W-A InvolvementResearch Evidence
AutophagyNegative regulationEnhanced autophagy upon deletion
Stb5 Transcriptional NetworkDownstream targetRegulated by Stb5 transcription factor
Ubiquitin-Proteasome SystemPotential interactionMentioned in context of UPS research

How does YMR315W-A antibody specificity compare to other yeast protein antibodies?

YMR315W-A antibodies are designed with high specificity for their target antigen. When comparing to other yeast protein antibodies, researchers should consider several key factors that influence specificity and experimental utility.

Most commercially available YMR315W-A antibodies undergo validation with recombinant proteins and have purity levels above 90% as confirmed by SDS-PAGE detection . The specificity is typically characterized through Western blotting against both recombinant target proteins and yeast cell lysates expressing endogenous proteins. Cross-reactivity testing against related yeast proteins is essential for determining true specificity.

Unlike antibodies against highly conserved proteins, YMR315W-A antibodies may show reduced cross-reactivity with other species, making them particularly valuable for yeast-specific studies but limiting their utility in cross-species comparisons. When selecting the appropriate antibody for your research, consider validation methods that align with your intended experimental applications.

What are the optimal conditions for using YMR315W-A antibody in Western blot experiments with yeast lysates?

For successful Western blot experiments with YMR315W-A antibody, the following optimized protocol has been developed based on research applications:

  • Sample preparation: For yeast lysates, utilize glass bead disruption in buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% Triton X-100, and a protease inhibitor cocktail. This method preserves protein integrity while efficiently extracting YMR315W-A .

  • Gel electrophoresis: Use 10-12% SDS-PAGE gels for optimal resolution of YMR315W-A, which appears at approximately its predicted molecular weight.

  • Transfer conditions: Transfer proteins to PVDF membranes (preferred over nitrocellulose) using a semi-dry transfer system at 15V for 45 minutes.

  • Blocking: Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature.

  • Primary antibody incubation: Dilute YMR315W-A antibody 1:1000 to 1:2000 in blocking solution and incubate overnight at 4°C for optimal signal-to-noise ratio .

  • Secondary antibody: Use HRP-conjugated anti-rabbit (if primary is rabbit-derived) at 1:5000 dilution for 1 hour at room temperature.

  • Detection: ECL-based chemiluminescence detection typically provides sufficient sensitivity without excessive background.

When troubleshooting, consider that expression levels of YMR315W-A may vary depending on yeast growth conditions, particularly during starvation or stress, which could affect detection sensitivity .

How can YMR315W-A antibody be effectively used to study autophagy regulation in yeast?

Given YMR315W-A's role in autophagy regulation, its antibody is a valuable tool for investigating this cellular process. Here's a methodological approach:

  • Autophagy induction monitoring: Use YMR315W-A antibody in conjunction with established autophagy markers (like Atg8) to track correlations between YMR315W-A levels and autophagy activation under various conditions. The research indicates chromosomal deletion of YMR315W enhances starvation-induced autophagy, suggesting inverse correlation between protein levels and autophagy activation .

  • Co-immunoprecipitation studies: Utilize the antibody to identify YMR315W-A interaction partners within the autophagy machinery:

    • Conduct pull-down experiments with YMR315W-A antibody from yeast extracts

    • Analyze precipitated complexes by mass spectrometry

    • Confirm interactions through reciprocal co-immunoprecipitation

    • Compare interaction profiles under normal and starvation conditions

  • Comparative analysis with Stb5-regulated proteins: Since YMR315W-A is a transcriptional target of Stb5, use the antibody to compare expression patterns with other Stb5 targets like ALD6 in wild-type and Stb5-deletion strains .

  • Subcellular localization studies: Employ YMR315W-A antibody in immunofluorescence microscopy to track protein localization during different stages of autophagy:

    • Compare normal growth conditions versus starvation

    • Monitor relocalization during autophagy induction

    • Quantify co-localization with autophagosomal markers

When designing these experiments, it's important to include appropriate controls such as YMR315W-A deletion strains to validate antibody specificity.

What are the critical parameters for validating YMR315W-A antibody specificity in yeast experiments?

Validating antibody specificity is crucial for generating reliable data. For YMR315W-A antibody, implement the following validation strategy:

  • Genetic validation: The gold standard approach involves testing the antibody in wild-type versus YMR315W-A deletion strains. The antibody should produce a clear signal in wild-type samples and no signal in deletion strains .

  • Peptide competition assay: Pre-incubate the antibody with excess purified antigen or immunizing peptide before application to samples. Disappearance of signal confirms specificity.

  • Multiple antibody comparison: When available, use antibodies raised against different epitopes of YMR315W-A and confirm similar detection patterns.

  • Expression modulation: Test antibody detection under conditions known to alter YMR315W-A expression, such as:

    • Starvation conditions (which may affect expression via Stb5-dependent regulation)

    • Stress conditions relevant to protein quality control pathways

  • Recombinant protein control: Include purified recombinant YMR315W-A protein as a positive control to confirm antibody recognition of the target epitope .

The validation data should be documented with appropriate controls and multiple experimental replicates to ensure reproducibility.

How should researchers optimize immunoprecipitation protocols for YMR315W-A when studying protein-protein interactions?

Optimizing immunoprecipitation (IP) protocols for YMR315W-A requires careful consideration of several parameters:

  • Lysis buffer optimization: For studying membrane-associated interactions or complexes:

    • Use buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% digitonin or 0.5% NP-40

    • Include protease inhibitors and phosphatase inhibitors

    • For ubiquitinated protein studies, add 10mM N-ethylmaleimide to prevent deubiquitination

  • Antibody coupling strategies:

    • Direct coupling to protein A/G beads may improve yield and reduce background

    • Covalent crosslinking using dimethyl pimelimidate can prevent antibody leaching during elution

    • For quantitative studies, standardize antibody amounts (typically 2-5μg per reaction)

  • Incubation conditions:

    • Slow rotation (rather than shaking) at 4°C

    • Typically 2-4 hours or overnight for weak interactions

    • Pre-clearing lysates with protein A/G beads alone reduces non-specific binding

  • Specialized protocols for detecting transient interactions:

    • Consider in vivo crosslinking with formaldehyde (0.1-1%) before lysis

    • For ubiquitinated protein interactions, adopt techniques similar to those used in studies of Cdc48p-associated ubiquitinated proteins

  • Elution and analysis strategies:

    • Gentle elution with excess peptide for native conditions

    • SDS-based elution for maximum recovery

    • Sequential elution for complex studies

Optimization experiments should systematically test these variables to determine the ideal conditions for your specific experimental questions.

How can researchers address contradictory results when studying YMR315W-A expression levels across different experimental conditions?

When encountering contradictory results regarding YMR315W-A expression, consider the following systematic approach:

  • Experimental variables assessment: Create a comprehensive table documenting all experimental conditions across conflicting studies:

VariableExperiment AExperiment BPotential Impact
Yeast strain backgrounde.g., BY4741e.g., W303Different backgrounds may have varying baseline expression
Growth phaseLog phaseStationaryExpression varies with growth phase
Media compositionCompleteMinimalNutritional status affects expression
Stress conditionsNoneOxidative stressStress response may alter expression
Detection methodWestern blotRT-qPCRProtein vs. mRNA levels may differ
  • Technical validation: Confirm antibody specificity and detection sensitivity across experiments:

    • Verify antibody lot consistency

    • Use multiple detection methods (Western blot and RT-qPCR)

    • Include appropriate loading controls

  • Biological context analysis: YMR315W-A is regulated by Stb5 and involved in autophagy regulation, so expression may naturally vary with:

    • Metabolic state of the cells

    • NADPH production pathway activity

    • Pentose phosphate pathway activation

    • Autophagy induction status

  • Integrated hypothesis testing: Design experiments specifically to address contradictions:

    • Time-course studies to capture dynamic expression changes

    • Single-cell analysis to identify potential heterogeneity within populations

    • Genetic manipulation (e.g., Stb5 deletion) to establish regulatory relationships

By systematically analyzing variables and validating results across multiple experimental approaches, researchers can resolve contradictions and develop a more complete understanding of YMR315W-A regulation.

What are common pitfalls in data interpretation when using YMR315W-A antibody in co-localization studies?

When conducting co-localization studies with YMR315W-A antibody, researchers should be aware of several common interpretation pitfalls:

  • Cross-reactivity misinterpretation: YMR315W-A antibody may recognize related proteins, leading to false co-localization signals. Validate specificity using:

    • YMR315W-A deletion controls

    • Peptide competition controls

    • Secondary antibody-only controls to rule out non-specific binding

  • Fixation artifacts: Different fixation methods can alter protein localization patterns:

    • Paraformaldehyde may preserve most structures but can cause some epitope masking

    • Methanol fixation may better preserve certain epitopes but can distort membranes

    • Compare multiple fixation protocols to confirm consistent localization patterns

  • Resolution limitations:

    • Standard fluorescence microscopy has ~200-250nm resolution limit

    • Proteins appearing co-localized might actually be separated but beyond resolution limits

    • Super-resolution microscopy techniques should be employed for definitive co-localization claims

  • Dynamic localization misinterpretation: YMR315W-A localization may change during:

    • Different cell cycle stages

    • Autophagy induction

    • Stress responses

    • Perform time-course experiments rather than single time-point imaging

  • Quantification challenges: Use rigorous quantification methods:

    • Apply proper statistical analysis to co-localization coefficients

    • Analyze sufficient cell numbers (typically >30 cells per condition)

    • Use automated, unbiased analysis tools to prevent confirmation bias

  • Background fluorescence interference: Yeast cell walls can contribute to background fluorescence. Implement:

    • Appropriate background subtraction

    • Careful selection of fluorophore combinations to minimize spectral overlap

    • Proper threshold setting during image analysis

By addressing these potential pitfalls through rigorous controls and appropriate analytical techniques, researchers can generate more reliable co-localization data with YMR315W-A antibody.

How can YMR315W-A antibody be utilized in studying the intersection between autophagy and the ubiquitin-proteasome system?

The intersection between autophagy and the ubiquitin-proteasome system (UPS) represents a frontier in cellular degradation research. YMR315W-A antibody can be leveraged in several sophisticated approaches:

  • Dual-system flux analysis: Monitor how perturbations in YMR315W-A levels affect the balance between autophagy and proteasomal degradation:

    • Use YMR315W-A antibody alongside UPS markers (ubiquitin, proteasome subunits) and autophagy markers (Atg8, Atg1)

    • Analyze changes in marker levels under conditions that inhibit either system

    • Quantify flux through each pathway using pulse-chase experiments with YMR315W-A antibody detection

  • Crosstalk mechanisms investigation: Explore if YMR315W-A functions as a decision point for substrate fate determination:

    • Perform immunoprecipitation with YMR315W-A antibody followed by ubiquitin detection to identify ubiquitinated binding partners

    • Compare binding partners under conditions favoring autophagy versus proteasomal degradation

    • Analyze post-translational modifications on YMR315W-A that might regulate its function in different degradation pathways

  • Regulatory network mapping: Use YMR315W-A antibody in ChIP-seq experiments with Stb5 to map the transcriptional regulation network connecting metabolic status to degradation pathways :

    • Identify Stb5 binding sites on the YMR315W promoter

    • Correlate Stb5 binding with YMR315W-A expression levels and autophagy/UPS activity

    • Map the complete regulatory network including other Stb5 targets

  • Stress response coordination: Investigate YMR315W-A's role in coordinating degradation responses during various cellular stresses:

    • Monitor YMR315W-A levels during ER stress, oxidative stress, and nutrient deprivation

    • Correlate with activation of UPS and autophagy

    • Determine if YMR315W-A serves as a molecular switch between degradation pathways

This research could reveal fundamental mechanisms by which cells coordinate multiple degradation systems, with implications for understanding diseases involving protein homeostasis dysregulation.

What methodological approaches can be used to study the role of YMR315W-A in NADPH-dependent metabolic regulation and its relationship to autophagy?

Research indicates YMR315W-A is a transcriptional target of Stb5, which regulates genes involved in NADPH production and the pentose phosphate pathway . This connection suggests YMR315W-A may link metabolic regulation to autophagy. To investigate this relationship:

  • Metabolic flux analysis with YMR315W-A perturbation:

    • Compare NADPH/NADP+ ratios in wild-type versus YMR315W-A deletion strains using enzymatic assays

    • Employ 13C-glucose labeling to track carbon flow through the pentose phosphate pathway with and without YMR315W-A

    • Correlate metabolic changes with autophagy markers

    • A methodological approach is shown below:

Experimental ConditionMeasurementTechniqueExpected Outcome if Hypothesis Correct
WT vs. YMR315W-A ΔNADPH/NADP+ ratioEnzymatic assayAltered ratio in mutant
WT vs. YMR315W-A ΔPentose phosphate intermediatesLC-MSChanged metabolite profile
WT vs. YMR315W-A ΔAutophagy markersWestern blotEnhanced autophagy in mutant
YMR315W-A overexpressionAll above parametersSame techniquesOpposite effects to deletion
  • Genetic interaction network mapping:

    • Perform synthetic genetic array analysis with YMR315W-A deletion as query

    • Focus on interactions with genes involved in NADPH metabolism and autophagy

    • Validate key interactions using double mutants and YMR315W-A antibody to track protein levels

  • Mechanistic studies of metabolic sensing:

    • Use YMR315W-A antibody to detect post-translational modifications under varying NADPH levels

    • Perform structure-function analysis to identify domains responsible for NADPH sensing

    • Create reporter systems based on YMR315W-A to monitor metabolic changes in real-time

  • Temporal relationship analysis:

    • Conduct time-course experiments following perturbation of NADPH levels

    • Use YMR315W-A antibody to track protein dynamics

    • Correlate changes with autophagy activation timing

    • Determine whether YMR315W-A changes precede or follow metabolic alterations

  • In vivo metabolic manipulation:

    • Force NADPH depletion through oxidative stress or enzyme inhibitors

    • Monitor YMR315W-A localization and abundance using the antibody

    • Track subsequent autophagy activation or inhibition

    • Test if YMR315W-A overexpression can rescue metabolic defects

These approaches would provide mechanistic insight into how YMR315W-A functions at the intersection of cellular metabolism and autophagy, potentially revealing new therapeutic targets for diseases involving dysregulated autophagy.

How does antibody-based detection of YMR315W-A compare to alternative protein detection methods in yeast studies?

When studying YMR315W-A in yeast, researchers have multiple detection options beyond antibody-based methods. This comparative analysis helps researchers select the optimal approach:

Detection MethodAdvantagesLimitationsBest Applications
YMR315W-A Antibody- Detects endogenous protein
- Works with fixed samples
- Compatible with various techniques (WB, IP, IF)
- Can detect post-translational modifications
- Potential cross-reactivity
- Batch variation
- May not work across species
- Some epitopes may be masked
- Endogenous protein studies
- Fixed tissue analysis
- Post-translational modification detection
GFP/RFP Tagging- Live cell imaging
- Real-time dynamics
- No antibody needed
- Quantifiable fluorescence
- Tag may affect function
- Requires genetic modification
- Autofluorescence background in yeast
- May alter expression levels
- Protein localization studies
- Protein dynamics
- FRAP experiments
- Protein-protein interactions (FRET)
TAP/FLAG Tagging- High specificity
- Excellent for purification
- Well-established in yeast
- Commercial detection reagents available
- Requires genetic modification
- Tag may interfere with function
- Not suitable for all applications
- Protein complex purification
- Interactome studies
- Chromatin immunoprecipitation
Mass Spectrometry- No tag or antibody needed
- Can identify novel modifications
- Highly sensitive
- Can be quantitative
- Expensive equipment
- Complex sample preparation
- Difficult for low abundance proteins
- Limited spatial information
- Proteome-wide studies
- Post-translational modification mapping
- Absolute quantification

For optimal results, researchers often combine multiple detection methods. For example, using YMR315W-A antibody validation alongside GFP-tagged versions provides complementary data and validation. Initial characterization with antibodies followed by more specialized techniques for specific experimental questions represents a sound methodological approach.

What emerging technologies might enhance the utility of YMR315W-A antibody in future research applications?

Several cutting-edge technologies are poised to transform how YMR315W-A antibody can be utilized in research:

  • Proximity labeling techniques:

    • BioID or TurboID fusions with YMR315W-A to map the local proteome

    • APEX2-based approaches for temporal control of proximity labeling

    • These approaches could reveal transient interactions missed by traditional immunoprecipitation

    • YMR315W-A antibody would be used for validation of identified interactors

  • Single-cell proteomics integration:

    • Combining YMR315W-A antibody with CyTOF or CODEX technologies

    • Analyzing heterogeneity in YMR315W-A expression within yeast populations

    • Correlating with single-cell transcriptomics data

    • Potential application for studying YMR315W-A in mixed microbial communities

  • Spatially-resolved proteomics:

    • Integration with multiplexed ion beam imaging (MIBI)

    • Combining with expansion microscopy for super-resolution

    • Development of split-epitope systems for protein-protein interaction visualization

    • YMR315W-A antibody fragments for improved penetration and resolution

  • Barcoded antibody approaches:

    • DNA-barcoded YMR315W-A antibodies for ultrasensitive detection

    • Integration with spatial transcriptomics

    • Multiplexed detection of YMR315W-A along with interaction partners

    • Potential for vastly improved quantification sensitivity

  • CRISPR-based techniques:

    • CUT&Tag approaches using YMR315W-A antibody for improved chromatin studies

    • Combining with CRISPR activation/inhibition systems to study regulatory networks

    • Development of degron-tagged variants for rapid protein depletion studies

    • Creation of optogenetic YMR315W-A variants for temporal control

  • AI-enhanced image analysis:

    • Machine learning algorithms for unbiased quantification of immunofluorescence

    • Automated detection of co-localization patterns

    • Pattern recognition across large datasets

    • Integration of multimodal data (proteomics, transcriptomics, metabolomics)

These emerging technologies promise to expand the utility of YMR315W-A antibodies beyond traditional applications, enabling more precise, sensitive, and comprehensive analyses of this protein's role in cellular processes, particularly at the intersection of metabolism and autophagy .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.